The 62-Year-Old with an 8 cm Sigmoid Mass and a Stented Left Colon
A 62-year-old man presents with a 3-day history of colicky left-sided abdominal pain and distension. CT shows an obstructing 8 cm sigmoid mass with proximal colonic dilation to 9 cm and no free air. A self-expanding metallic stent is placed by endoscopy with successful decompression. Staging CT shows no distant metastases, and pelvic MRI shows a T3N1 tumor without threatened margins. His comorbidities include insulin-dependent diabetes (HbA1c 9.1%), a BMI of 38, and stable angina. The tumor board must decide between bridge-to-surgery and upfront surgery, and whether to operate now or after optimization. The patient asks whether the stent has already 'fixed' the emergency.
1. How should the team weigh bridge-to-surgery stenting versus emergency resection in this patient, and what does the evidence say about short- and long-term outcomes?
Read the worked answer
This is a malignant left-sided obstruction without perforation or peritonitis, so the two strategies are emergency resection (with or without primary anastomosis) versus stent as a bridge to elective surgery.
Short term: meta-analyses of bridge-to-surgery stenting show lower perioperative morbidity, fewer temporary stomas, and higher rates of primary anastomosis and laparoscopic completion, at the cost of a small stent-related perforation risk (roughly 3-5%). Given his poorly controlled diabetes, obesity, and cardiac disease, avoiding a stoma and an emergency operation is a meaningful gain.
Long term: the concern is oncologic safety. Randomized data (e.g., the CReST trial) did not show worse overall or disease-free survival with stenting, though some earlier observational signals of increased recurrence raised caution. Stenting is therefore acceptable as a bridge when it converts an emergency into an elective, optimized operation - not as definitive palliation in a fit patient.
The judgment call: the benefit hinges on whether optimization is real. This patient's HbA1c of 9.1% and angina warrant a defined optimization window (glycemic control, cardiac risk assessment) and a planned resection within a few weeks. If optimization cannot occur or the stent fails, proceed to surgery. Answer the patient directly: the stent relieved the obstruction but did not treat the cancer.
2. What is the appropriate operative plan if the team elects resection, and how do his comorbidities change the anastomotic decision?
Read the worked answer
Elective sigmoid colectomy with high ligation of the inferior mesenteric vessels and adequate proximal margin, ideally laparoscopic or robotic given the obesity (which raises conversion risk but does not contraindicate minimally invasive approach in experienced hands).
Anastomotic decision: a primary stapled colorectal anastomosis is reasonable in an optimized, decompressed, non-perforated patient. His diabetes and obesity are relative risks for leak, so the team should optimize glycemia preoperatively, ensure adequate perfusion and tension-free technique, and consider proximal diversion only if the anastomosis is technically marginal. Routine diversion for comorbidity alone is not mandated.
If the tumor proves unresectable or perforated intraoperatively, the plan changes to diversion or Hartmann's. Document the contingency in the consent discussion.